Where can prostate cancer metastasize to?

Written by Zhou Zi Hua
Oncology
Updated on September 20, 2024
00:00
00:00

When prostate cancer invades surrounding tissues and structures, it can cause a variety of clinical symptoms, including urinary irritation, urinary obstruction, urinary incontinence, sciatica, erectile dysfunction, etc., and can compress causing unilateral or bilateral hydronephrosis. In severe cases, when the tumor invades the rectum, it can cause difficulty in defecation or colon obstruction. When the cancer metastasizes to the bones, it can cause bone pain and pathological fractures, and may also spread to the lungs.

Other Voices

doctor image
home-news-image
Written by Yan Chun
Oncology
1min 9sec home-news-image

Will prostate cancer embryonic antigen rise?

Prostate cancer is a common malignant tumor in the male urinary system. In some patients with prostate issues, there may be an increase in the carcinoembryonic antigen index in blood tests, but not all patients will exhibit this marker increase. Most prostate cancer patients will show an increase in the prostate-specific antigen (PSA) in blood tests, or there may be abnormal ratios of free PSA to bound PSA. Carcinoembryonic antigen and prostate-specific antigen are tumor markers for prostate cancer, but they only provide auxiliary value for diagnosis and do have some evaluative value regarding the effectiveness of anti-tumor treatment. Additionally, they can serve as a monitor for the condition of prostate cancer. Clinically, to confirm a diagnosis of prostate cancer, it is necessary to rely on the results of pathological tissue obtained through biopsy.

doctor image
home-news-image
Written by Liu Liang
Oncology
48sec home-news-image

How is prostate cancer formed?

The causes of prostate cancer are not yet very clear. According to relevant data analysis, the occurrence of prostate cancer may be related to prostate gonorrhea, infections with viruses or chlamydia, as well as the intensity of sexual activity and the impact of hormones. On the other hand, a high-fat diet and some occupational factors are also somewhat related to the disease. Therefore, the formation of prostate cancer is the result of multifactorial influences including environmental and genetic factors, personal lifestyle habits, and dietary habits, all of which are significantly interconnected.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
40sec home-news-image

androgen deprivation therapy for prostate cancer

Androgen deprivation therapy for prostate cancer includes surgical castration, which can quickly and continuously reduce levels to very low levels. The second is medical castration, which involves the use of analogs of luteinizing hormone-releasing hormone. Currently available products include leuprolide, goserelin, and triptorelin. Third, estrogen therapy, with diethylstilbestrol being the most common estrogen treatment. Surgical castration, medical castration, or estrogen therapy offer similar progression-free survival rates in patients with tumor-related outcomes.

doctor image
home-news-image
Written by Liu Liang
Oncology
45sec home-news-image

Can prostate cancer be detected by ultrasound B?

Prostate cancer can generally be detected through ultrasound, as it reveals nodules in the prostate. By examining the internal echoes of these nodules, one can differentiate between benign and malignant prostate conditions. Thus, in foreign countries, ultrasound, specifically prostate color Doppler ultrasound examinations, are used as a screening method for prostate cancer. In China, screening methods also include traditional digital rectal examinations and generally involve blood tests for specific prostate tumor markers, namely PSA. These tests are combined with prostate ultrasound for a comprehensive assessment.

doctor image
home-news-image
Written by Zhou Zi Hua
Oncology
40sec home-news-image

Prostate Cancer Treatment Options

How is prostate cancer treated? The choice of treatment plan should be based on a comprehensive consideration of the patient's clinical stage, age, overall health, and expected lifespan. For example, in the early stages of prostate cancer, one can choose postoperative radical radiotherapy after prostatectomy. For locally advanced prostate cancer, radiotherapy, intensified radiotherapy combined with endocrine therapy can be chosen. For metastatic prostate cancer, endocrine therapy is mainly used, and chemotherapy can be adopted for those who are ineffective or fail endocrine therapy.